Insurance Healthcare Sector

CareDx

Market Cap: US$896.5m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

Spyre Therapeutics

Market Cap: US$877.5m

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

Enliven Therapeutics

Market Cap: US$874.4m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Extendicare

Market Cap: CA$1.2b

Through its subsidiaries, provides care and services for seniors in Canada.

Pharvaris

Market Cap: US$867.0m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Avadel Pharmaceuticals

Market Cap: US$860.0m

Operates as a biopharmaceutical company in the United States.

AMN Healthcare Services

Market Cap: US$856.8m

Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

HealthStream

Market Cap: US$841.6m

Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

Intellia Therapeutics

Market Cap: US$836.4m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

Niagen Bioscience

Market Cap: US$828.8m

Operates as a bioscience company engages in developing healthy aging products.

Ardelyx

Market Cap: US$808.7m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Cronos Group

Market Cap: CA$1.1b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

SI-BONE

Market Cap: US$804.6m

A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

Zymeworks

Market Cap: US$803.5m

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

CorMedix

Market Cap: US$792.9m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Bicara Therapeutics

Market Cap: US$789.1m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

CureVac

Market Cap: US$771.2m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Geron

Market Cap: US$770.7m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Syndax Pharmaceuticals

Market Cap: US$770.1m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

LENZ Therapeutics

Market Cap: US$769.5m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Xeris Biopharma Holdings

Market Cap: US$767.1m

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Nuvation Bio

Market Cap: US$762.2m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Praxis Precision Medicines

Market Cap: US$757.7m

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

Veradigm

Market Cap: US$755.1m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

uniQure

Market Cap: US$750.1m

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

WELL Health Technologies

Market Cap: CA$1.0b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

Rocket Pharmaceuticals

Market Cap: US$724.5m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Nurix Therapeutics

Market Cap: US$721.2m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Anavex Life Sciences

Market Cap: US$714.6m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

Immunome

Market Cap: US$696.1m

A clinical-stage biotechnology company, develops targeted cancer therapies.

IRADIMED

Market Cap: US$684.8m

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.

Embecta

Market Cap: US$681.4m

A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.

Nika Pharmaceuticals

Market Cap: US$672.8m

Engages in the development and distribution of various pharmaceutical products.

Curaleaf Holdings

Market Cap: CA$939.2m

Produces and distributes cannabis products in the United States and internationally.

Akebia Therapeutics

Market Cap: US$667.1m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

GH Research

Market Cap: US$663.7m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.